ACACIA-HCM 试验达到了两项主要终点，有望将治疗拓展至新的心肌病患者群体。
qz.com
Cytokinetics stock hits 52-week high after heart drug passes expanded Phase 3 trial
RSS Hunter
2026-05-05
Create attached notes ...